Animal models of inflammatory bowel disease: an overview - PubMed (original) (raw)
Review
Animal models of inflammatory bowel disease: an overview
Jörg C Hoffmann et al. Pathobiology. 2002.
Abstract
Inflammatory bowel disease (IBD) research has been performed in human in vitro studies and in in vivo studies using appropriate animal models. Such animal models allow both the examination of inflammatory processes (both early and late events) as well as the evaluation of new therapeutic modalities. Since the first description of the immune complex colitis in rabbits in 1961, overall 63 models have been described, most of which within the last decade. These IBD animal models can be divided into 5 different categories: (1) antigen-induced colitis and colitis induced by microbials; (2) other inducible forms of colitis (chemical, immunological, and physical); (3) genetic colitis models (transgenic and knock-out models); (4) adoptive transfer models, and (5) spontaneous colitis models. In spite of the high overall number of models, none of them is the 'perfect' model and therefore numerous aspects need to be considered when choosing one model for a particular study. Importantly, most clinical aspects (e.g. extraintestinal manifestations or fistula) have recently been described in one or the other model allowing further studies with relevance for almost all aspects of IBD. So far, IBD animal models have taught us important lessons, e.g. the requirement of T-helper cells in most models, the need of a particular genetic background, and the role of the flora in the initiation of IBD. It is expected that our understanding of IBD will further increase in a number of additional areas using animal models, e.g. exploring the role of the innate immune system in IBD.
Copyright 2003 S. Karger AG, Basel
Similar articles
- Animal models of inflammatory bowel diseases: illuminating the pathogenesis of colitis, ileitis and cancer.
Neurath MF. Neurath MF. Dig Dis. 2012;30 Suppl 1:91-4. doi: 10.1159/000341131. Epub 2012 Oct 11. Dig Dis. 2012. PMID: 23075875 Review. - Animal models of inflammatory bowel disease.
Jurjus AR, Khoury NN, Reimund JM. Jurjus AR, et al. J Pharmacol Toxicol Methods. 2004 Sep-Oct;50(2):81-92. doi: 10.1016/j.vascn.2003.12.002. J Pharmacol Toxicol Methods. 2004. PMID: 15385082 Review. - Lessons from genetic models of inflammatory bowel disease.
Podolsky DK. Podolsky DK. Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5. Acta Gastroenterol Belg. 1997. PMID: 9260328 Review. - Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
Powrie F, Uhlig H. Powrie F, et al. Novartis Found Symp. 2004;263:164-74; discussion 174-8, 211-8. Novartis Found Symp. 2004. PMID: 15669641 Review. - High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K, Kutlu B, Fox B, Serikawa K, Lord J, Hansen AK, Holm TL. Holgersen K, et al. J Crohns Colitis. 2015 Jun;9(6):492-506. doi: 10.1093/ecco-jcc/jjv050. Epub 2015 Mar 20. J Crohns Colitis. 2015. PMID: 25795566
Cited by
- Ferulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, oxidative stress, iNOs, COX-2, and apoptosis in laboratory rats.
Sadar SS, Vyawahare NS, Bodhankar SL. Sadar SS, et al. EXCLI J. 2016 Aug 9;15:482-499. doi: 10.17179/excli2016-393. eCollection 2016. EXCLI J. 2016. PMID: 27822176 Free PMC article. - Autoimmunity against type VII collagen in inflammatory bowel disease.
Hundorfean G, Neurath MF, Sitaru C. Hundorfean G, et al. J Cell Mol Med. 2010 Oct;14(10):2393-403. doi: 10.1111/j.1582-4934.2009.00959.x. J Cell Mol Med. 2010. PMID: 19878366 Free PMC article. Review. - Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.
Oliveira GG, Holton J, Lydyard PM. Oliveira GG, et al. Gut Microbes. 2010 Sep;1(5):345-355. doi: 10.4161/gmic.1.5.13136. Epub 2010 May 24. Gut Microbes. 2010. PMID: 21327045 Free PMC article. - 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Tang H, Xiang D, Wang F, Mao J, Tan X, Wang Y. Tang H, et al. Mol Med Rep. 2017 Mar;15(3):1117-1122. doi: 10.3892/mmr.2017.6153. Epub 2017 Jan 26. Mol Med Rep. 2017. PMID: 28138699 Free PMC article. - Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
Storr MA, Keenan CM, Emmerdinger D, Zhang H, Yüce B, Sibaev A, Massa F, Buckley NE, Lutz B, Göke B, Brand S, Patel KD, Sharkey KA. Storr MA, et al. J Mol Med (Berl). 2008 Aug;86(8):925-36. doi: 10.1007/s00109-008-0359-6. Epub 2008 May 21. J Mol Med (Berl). 2008. PMID: 18493729
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases